Documento de consenso SEDAR/SECCE sobre el manejo de ECMO

Zarragoikoetxea, Iratxe; Pajares, A.; Moreno, Iván Sánchez; Porta, Juan Ignacio Dalmau; Koller, Tobias; Cegarra, V.; González, Ana; Eiras, Margarida; Sandoval, Elena; Sarralde, J.A.; Quintana‐Villamandos, Begoña; Guillén, Rosario Vicente

doi:10.1016/j.circv.2021.06.006

Cited by 2 publications

(2 citation statements)

References 187 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…To overcome this situation, options include modifying the cannulas’ configuration for a venous-arterial-venous ECMO (triple cannulation strategy using an internal jugular vein or femoral vein) or venous-venous-arterial ECMO (in cases of right ventricular (RV) dysfunction), changing the arterial femoral inflow cannula toward an axillary return, decreasing ECMO flow, or converting to a central cannulation. 4 …”

Section: Reviewmentioning

confidence: 99%

Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO)

Swedzky¹,

Barbagelata²,

Perrone³

et al. 2023

DIC

View full text Add to dashboard Cite

Circulatory support with extracorporeal membrane oxygenation (ECMO) is being increasingly used in several critical situations but evidence of its impact on outcomes is inconsistent. Understanding of the specific indications and appropriate timing of implantation of this technology might lead to improved results. Indeed, the line between success and futility may be sometimes very thin when facing a patient in critical condition. New techniques with lighter, simpler and effective devices are being developed. Hence, ECMO has become an accessible technology that is being increasingly used outside of the operating room by heart failure specialists, critical care cardiologists and intensivists. Proper timing of utilization and choice of device may lead to better outcomes. We herein aim to improve this knowledge gap by conducting a literature review to provide simple information, evidence-based indications and a practical approach for cardiologists who may encounter acutely ill adult patients that may be ECMO candidates. This article is part of the Emerging concepts in heart failure management and treatment Special Issue: https://www.drugsincontext.com/special_issues/emerging-concepts-in-heart-failure-management-and-treatment

show abstract

Section: Reviewmentioning

confidence: 99%

Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO)

Swedzky¹,

Barbagelata²,

Perrone³

et al. 2023

DIC

View full text Add to dashboard Cite

show abstract

“…Se emplea en pacientes sin respuesta a la terapéutica y en instituciones de tercer nivel, en relación con este nivel de complejidad. Está indicada en las siguientes circunstancias: presión capilar pulmonar en cuña (PCWC) superiores a los 18 milímetro de mercurio (mmHg) y un índice cardiaco IC menor a 2,5 L/ min/m 2 (Zarragoikoetxea et al, 2021) (Figura 15 y 16). • Accidente vascular cerebral hemorrágico.…”

Section: Tratamiento Obstétricounclassified

Patologías tromboembólicas de alta mortalidad durante el embarazo, parto y puerperio

Paneque¹,

Fernández²,

Posada³

et al. 2022

View full text Add to dashboard Cite

show abstract

Documento de consenso SEDAR/SECCE sobre el manejo de ECMO

Cited by 2 publications

References 187 publications

Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO)

Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO)

Patologías tromboembólicas de alta mortalidad durante el embarazo, parto y puerperio

Contact Info

Product

Resources

About